BioHarvest Sciences Cost of Goods Sold 2020-2024 | BHST
BioHarvest Sciences cost of goods sold from 2020 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
BioHarvest Sciences Annual Cost of Goods Sold
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$4 |
| 2021 |
$1 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2019 |
$ |
| 2018 |
$ |
BioHarvest Sciences Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-06-30 |
$3 |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$2 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$1 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$1 |
| 2022-06-30 |
$1 |
| 2022-03-31 |
$1 |
| 2021-12-31 |
$0 |
| 2021-09-30 |
$0 |
| 2021-06-30 |
$0 |
| 2021-03-31 |
$0 |
| 2020-12-31 |
$0 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
|
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
